⌘K

Login Start Free

Home/Filings/4/0001144204-13-010403

4//SEC Filing

COMMISSIONG GERALD 4

Accession 0001144204-13-010403

CIK 0001424812other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 10:02 AM ET

Size

21.0 KB

Accession

0001144204-13-010403

Insider Transaction Report

Form 4

Period: 2013-02-21

AMARANTUS BIOSCIENCE, INC.AMBS

COMMISSIONG GERALD

DirectorCEO10% Owner

Transactions

Purchase
Common Stock
2013-01-11$0.07/sh+10,000$742→ 7,502,300 total
Purchase
Common Stock
2013-01-11$0.07/sh+15,000$1,115→ 7,517,300 total
Purchase
Common Stock
2013-01-11$0.07/sh+15,000$1,115→ 7,517,300 total
Purchase
Common Stock
2013-01-14$0.09/sh+15,000$1,365→ 7,542,300 total
Purchase
Common Stock
2013-02-05$0.08/sh+47,900$4,019→ 7,590,200 total
Purchase
Common Stock
2013-02-05$0.08/sh+2,100$176→ 7,592,300 total
Purchase
Common Stock
2013-02-21$0.07/sh+50,000$3,625→ 7,642,300 total
Award
Common Stock Options
2011-05-04$0.03/sh+269,329$7,272→ 269,329 total
Exercise: $0.03→ CommonStock (269,329 underlying)
Award
5% Convertible Preferred Stock
2012-07-15+471,250→ 23,531,829 total
Exercise: $1.50→ Common Stock (23,562,500 underlying)
Award
5% Convertible Preferred Stock
2012-11-04+500,000→ 48,531,829 total
Exercise: $1.50→ CommonStock (25,000,000 underlying)

Footnotes (3)

[F1]No specific date set.
[F2]Set based upon current price, actual price will be determined on the date of conversion.
[F3]N/A

Documents

1 file

4
v335855_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

AMARANTUS BIOSCIENCE, INC.

CIK 0001424812

Entity typeother

Related Parties

1

filerCIK 0001566928

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 10:02 AM ET
Size: 21.0 KB

View on SEC.gov